JP2010500286A5 - - Google Patents

Download PDF

Info

Publication number
JP2010500286A5
JP2010500286A5 JP2009521936A JP2009521936A JP2010500286A5 JP 2010500286 A5 JP2010500286 A5 JP 2010500286A5 JP 2009521936 A JP2009521936 A JP 2009521936A JP 2009521936 A JP2009521936 A JP 2009521936A JP 2010500286 A5 JP2010500286 A5 JP 2010500286A5
Authority
JP
Japan
Prior art keywords
composition
rapamycin analog
acetate
powder
ray diffraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009521936A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010500286A (ja
Filing date
Publication date
Priority claimed from US11/781,807 external-priority patent/US7820812B2/en
Priority claimed from US11/781,804 external-priority patent/US7812032B2/en
Application filed filed Critical
Priority claimed from PCT/US2007/074159 external-priority patent/WO2008014222A1/en
Publication of JP2010500286A publication Critical patent/JP2010500286A/ja
Publication of JP2010500286A5 publication Critical patent/JP2010500286A5/ja
Pending legal-status Critical Current

Links

JP2009521936A 2006-07-25 2007-07-24 結晶形態のラパマイシン類似体 Pending JP2010500286A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US82031706P 2006-07-25 2006-07-25
US11/781,807 US7820812B2 (en) 2006-07-25 2007-07-23 Methods of manufacturing crystalline forms of rapamycin analogs
US11/781,804 US7812032B2 (en) 2006-07-25 2007-07-23 Crystalline forms of rapamycin analogs
PCT/US2007/074159 WO2008014222A1 (en) 2006-07-25 2007-07-24 Crystalline forms of rapamycin analogs

Publications (2)

Publication Number Publication Date
JP2010500286A JP2010500286A (ja) 2010-01-07
JP2010500286A5 true JP2010500286A5 (enExample) 2010-09-09

Family

ID=38562825

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009521936A Pending JP2010500286A (ja) 2006-07-25 2007-07-24 結晶形態のラパマイシン類似体

Country Status (10)

Country Link
EP (2) EP2051984A1 (enExample)
JP (1) JP2010500286A (enExample)
KR (1) KR20090035716A (enExample)
AU (1) AU2007276837B2 (enExample)
BR (1) BRPI0714945B8 (enExample)
CA (1) CA2658896A1 (enExample)
IL (1) IL196706A0 (enExample)
MX (1) MX2009001067A (enExample)
NZ (1) NZ574654A (enExample)
WO (1) WO2008014222A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820812B2 (en) 2006-07-25 2010-10-26 Abbott Laboratories Methods of manufacturing crystalline forms of rapamycin analogs
US7812032B2 (en) 2006-07-25 2010-10-12 Abbott Laboratories Crystalline forms of rapamycin analogs
RU2458710C2 (ru) 2007-01-21 2012-08-20 Хемотек Аг Медицинский продукт для лечения обтураций просветов организма и для предупреждения угрожающих повторных обтураций
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
CA2749807C (en) * 2009-01-21 2015-09-29 Biocon Limited A method for determination of sirolimus stability and process for preparing its stable form
ES2550634T3 (es) 2009-07-10 2015-11-11 Boston Scientific Scimed, Inc. Uso de nanocristales para un balón de suministro de fármaco
JP5933434B2 (ja) 2009-07-17 2016-06-08 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. 薬剤送達バルーンの製造方法
US8889211B2 (en) 2010-09-02 2014-11-18 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
US8669360B2 (en) 2011-08-05 2014-03-11 Boston Scientific Scimed, Inc. Methods of converting amorphous drug substance into crystalline form
WO2013028208A1 (en) 2011-08-25 2013-02-28 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
US9439892B2 (en) 2013-05-16 2016-09-13 Surmodics, Inc. Macrolide particulates, methods for preparation, and medical devices associated therewith
JP6416242B2 (ja) * 2013-06-12 2018-10-31 サーモディクス,インコーポレイティド 結晶性マクロライド微粒子を調製するための溶剤法、組成物、および微粒子を含む物品
DE102013110294B4 (de) * 2013-09-18 2016-07-07 Innora Gmbh Limus-Depot-Formulierung auf Ballonkathetern
WO2017173121A1 (en) 2016-03-31 2017-10-05 Surmodics, Inc. Drug-containing particulate composition with cationic agent, associated medical devices, and methods for treatment
US11123459B2 (en) 2016-12-16 2021-09-21 Surmodics, Inc. Hydrophobic active agent particle coatings and methods for treatment
CN108144131A (zh) * 2017-12-22 2018-06-12 上海微创医疗器械(集团)有限公司 一种载药植入医疗器械及其制备方法
JP2023519875A (ja) * 2020-03-27 2023-05-15 ボストン サイエンティフィック サイムド,インコーポレイテッド 薬品の結晶化のための方法
JP2024503898A (ja) * 2021-01-22 2024-01-29 ヤンセン ファーマシューティカ エヌ.ベー. ラパマイシン類似体及びその使用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527907A (en) 1993-11-19 1996-06-18 Abbott Laboratories Macrolide immunomodulators
US20030129215A1 (en) * 1998-09-24 2003-07-10 T-Ram, Inc. Medical devices containing rapamycin analogs
US6015815A (en) * 1997-09-26 2000-01-18 Abbott Laboratories Tetrazole-containing rapamycin analogs with shortened half-lives
TW557297B (en) * 1997-09-26 2003-10-11 Abbott Lab Rapamycin analogs having immunomodulatory activity, and pharmaceutical compositions containing same
IL150524A0 (en) * 2000-01-07 2003-02-12 Transform Pharmaceuticals Inc High-throughput formation, identification, and analysis of diverse solid-forms
AR050374A1 (es) * 2004-08-20 2006-10-18 Wyeth Corp Forma polimorfica de rafampicina
WO2006060615A1 (en) * 2004-12-01 2006-06-08 Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg Non-hygroscopic and powdery amorphous pimecrolimus

Similar Documents

Publication Publication Date Title
RU2482119C2 (ru) Кристаллические формы аналогов рапамицина
JP2010536889A5 (enExample)
JP2019514874A5 (enExample)
JP2005053931A5 (enExample)
JP2010540541A5 (enExample)
RU2018145948A (ru) Кристалл пирролопиримидина для получения jak-ингибитора
JP2009263394A5 (enExample)
JP2013505929A5 (enExample)
HRP20141137T1 (hr) Polimorfni oblici macrocikliäśkog inhibitora hcv
JP2011528658A5 (enExample)
JP2015508092A5 (enExample)
JP2011518775A5 (enExample)
JP2010536766A5 (enExample)
JP2012092103A5 (enExample)
US11384077B2 (en) Solid state form of Valbenazine
JP2009520766A5 (enExample)
JP2014518240A5 (enExample)
JP2014530818A5 (enExample)
JP2010508310A5 (enExample)
RU2016118796A (ru) Новая кристаллическая форма 2-{ 3-[2-(1-{ [3, 5-бис(дифторметил)-1н-пиразол-1-ил]ацетил} пиперидин-4-ил)-1, 3-тиазол-4-ил]-4, 5-дигидро-1, 2-оксазол-5-ил} -3-хлорфенилметансульфоната
JP2022060192A5 (enExample)
JP2011528662A5 (enExample)
JP2012511558A5 (enExample)
JP2011529942A5 (enExample)
JP2016510767A5 (enExample)